08:58 AM EDT, 06/16/2026 (MT Newswires) -- Healthcare stocks were steady pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) unchanged.

Zai Lab ( ZLAB ) stock was up more than 2% after the company said the European Medicines Agency has granted orphan drug designation to its experimental therapy, zocilurtatug pelitecan, for the treatment of pulmonary neuroendocrine carcinomas, a type of lung cancer.